Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | DCUN1D1 | Q96GG9 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 6/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.38 |
| ▸ | NPC1 | O15118 | 5/20 | 0.38 |
| ▸ | CASP3 | P42574 | 1/20 | 0.38 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.38 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.38 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.38 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.37 |
| ▸ | CACNG8 | Q8WXS5 | 1/20 | 0.37 |
| ▸ | NMT2 | O60551 | 1/20 | 0.37 |
| ▸ | NMT1 | P30419 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.37 |
| ▸ | HPGD | P15428 | 4/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9161616 | 0.88 | TRPA1 (0.43) | TRPA1GAADCUN1D1RAB9ASMN1; SMN2 | |
| SCHEMBL3652857 | 0.88 | NR1H4 (0.43) | TRPA1GAARAB9ASMN1; SMN2NPC1 | |
| SCHEMBL16174501 | 0.86 | P2RX7 (0.35) | TRPA1GAADCUN1D1RAB9ASMN1; SMN2 | |
| SCHEMBL918324 | 0.84 | DCUN1D1 (0.47) | TRPA1GAADCUN1D1RAB9ASMN1; SMN2 | |
| SCHEMBL16174504 | 0.82 | CYP1A2 (0.36) | SMN1; SMN2MAPTKDM4E | |
| SCHEMBL27761643 | 0.81 | GAA (0.44) | TRPA1GAADCUN1D1RAB9ASMN1; SMN2 | |
| SCHEMBL16174509 | 0.80 | CYP1A2 (0.34) | DCUN1D1RAB9ASMN1; SMN2NPC1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL27741149 | 0.79 | GAA (0.43) | TRPA1GAADCUN1D1RAB9ASMN1; SMN2 | |
| SCHEMBL17751101 | 0.78 | NPC1 (0.38) | RAB9ANPC1CASP3SENP8SENP7 | |
| SCHEMBL16174505 | 0.77 | METAP2 (0.38) | RAB9ASMN1; SMN2NPC1ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9012655-B2 | Antimicrobial/adjuvant compounds and methods | Denouamed, Inc. (CA) | 2015-04-21 | — | — | US | disclosed |
| US-20140309266-A1 | ANTIMICROBIAL/ADJUVANT COMPOUNDS AND METHODS | DENOVAMED INC. (CA) | 2014-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140309266-A1 | ANTIMICROBIAL/ADJUVANT COMPOUNDS AND METHODS | S100A11, IFNG, MYD88 | TRPA1 4014/4885GAA 2175/4885DCUN1D1 2158/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.